Urgent care or ER? With ‘one-stop shop,’ hospitals offer both under same roof

Facing an ultracompetitive market in one of the nation’s fastest-growing cities, UF Health is trying a new way to attract patients: a combination emergency room and urgent care center.

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease – Biotech Investments

EQS-News: ABIVAX / Key word(s): Study Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease 03.10.2024 / 22:01

October 4, 2024

Sarepta shares PhII data for next-gen exon skipping drug, but regulatory pathway is unclear

Sarepta Therapeutics announced Monday that its experimental Duchenne muscular dystrophy drug led to some expression of dystrophin — the muscle protein that is mutated in

January 30, 2024

Novo Nordisk’s obesity pill bests Wegovy in early trial

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.